Rob Albert | Association for Accessible Medicines
AAM All Access Podcast - AAM CEO Dan Leonard convenes industry and policy experts to explore why the Inflation Reduction Act (f/k/a Build Back Better) reduces generic and biosimilar competition.

Rob Albert

AAM Board Member
Senior Vice President and Chief Marketing Officer, B. Braun Medical Inc.
Rob Albert
Rob Albert
B. Braun Medical Inc.

Rob Albert has been employed by B. Braun Medical Inc., a leading global medical device and pharmaceutical company with US headquarters in Bethlehem, PA., his entire career. He currently holds the position of Sr. Vice President and Chief Marketing Officer, responsible for all marketing activities in the United States and Canada.

Rob also serves as Chairman of the Board of CAPS (Central Admixture Pharmacy Services, Inc.), part of the B. Braun group of companies in the US. CAPS is a network of 25 pharmacies located across the country providing outsourced pharmacy compounding services to over 1200 hospitals and homecare companies.

Rob also serves as a Director on the Board of B. Braun of Canada and as a member of the Foundation Board of Northampton Community College. He holds a BS degree in Business Management and Marketing from Clarion University.

Latest Tweets

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.